Interleukin-10 and the regulation of mitogen-activated protein kinases:: are these signalling modules targets for the anti-inflammatory action of this cytokine?

被引:56
作者
Haddad, JJ
Saadé, NE
Safieh-Garabedian, B
机构
[1] Univ Calif San Francisco, Sch Med, Dept Anesthesia & Perioperat Care, Mol Neurosci Res Div,Severinghaus Radiometer Res L, San Francisco, CA 94143 USA
[2] Amer Univ Beirut, Fac Arts & Sci, Dept Biol, Beirut 110236, Lebanon
[3] Amer Univ Beirut, Fac Med, Dept Human Morphol & Physiol, Div Mol & Behav Neurosci, Beirut 110236, Lebanon
[4] Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA
基金
英国医学研究理事会; 英国惠康基金; 美国国家卫生研究院;
关键词
cell signalling; cytokine; disease; IL-10; immunopharmacology; inflammation; kinase; MAPK;
D O I
10.1016/S0898-6568(02)00075-X
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The many specific, yet overlapping and redundant activities of individual cytokines have been the basis for current concepts of therapeutical intervention. Cytokines are powerful two-edged weapons that can trigger a cascade of reactions and may show activities that often go beyond the single highly specific property that it is hoped they possess. Nevertheless, it can be stated that our new, though burgeoning, understanding of the biological mechanisms governing cytokine actions is an important contribution to medical knowledge. The crucial role of the anti-inflammatory cytokine, interleukin (IL)-10, in regulating potential molecular pathway mediating injury and cell death has attracted paramount attention in recent years. In this respect, the mitogen-activated protein kinase (MAPK) components have emerged as potential signalling cascades that regulate a plethora of cell functions, including inflammation and cell death. The biochemistry and molecular biology of cytokine actions, particularly IL-10, explain some well known and sometimes also some of the more obscure clinical aspects of the evolution of diseases. (C) 2002 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:255 / 267
页数:13
相关论文
共 145 条
[71]  
2-Z
[72]  
Lazarov S, 2000, Vutr Boles, V32, P33
[73]   Role of CSBP/p38/RK stress response kinase in LPS and cytokine signaling mechanisms [J].
Lee, JC ;
Young, PR .
JOURNAL OF LEUKOCYTE BIOLOGY, 1996, 59 (02) :152-157
[74]   Inhibition of p38 MAP kinase as a therapeutic strategy [J].
Lee, JC ;
Kumar, S ;
Griswold, DE ;
Underwood, DC ;
Votta, BJ ;
Adams, JL .
IMMUNOPHARMACOLOGY, 2000, 47 (2-3) :185-201
[75]   The Raf/MEK/ERK signal transduction cascade as a target for chemotherapeutic intervention in leukemia [J].
Lee, JT ;
McCubrey, JA .
LEUKEMIA, 2002, 16 (04) :486-507
[76]   Diverse functions of JNK signaling and c-Jun in stress response and apoptosis [J].
Leppä, S ;
Bohmann, D .
ONCOGENE, 1999, 18 (45) :6158-6162
[77]   Cellular functions of plasma membrane estrogen receptors [J].
Levin, ER .
STEROIDS, 2002, 67 (06) :471-475
[78]   Signal transduction through MAP kinase cascades [J].
Lewis, TS ;
Shapiro, PS ;
Ahn, NG .
ADVANCES IN CANCER RESEARCH, VOL 74, 1998, 74 :49-139
[79]   Regulation of MAP kinase activity by peptide receptor signalling pathway: Paradigms of multiplicity [J].
Liebmann, C .
CELLULAR SIGNALLING, 2001, 13 (11) :777-785
[80]   Distinct role of p38 and c-Jun N-terminal kinases in IL-10-dependent and IL-10-independent regulation of the costimulatory molecule B7.2 in lipopolysaccharide-stimulated human monocytic cells [J].
Lim, W ;
Ma, W ;
Gee, K ;
Aucoin, S ;
Nandan, D ;
Diaz-Mitoma, F ;
Kozlowski, M ;
Kumar, A .
JOURNAL OF IMMUNOLOGY, 2002, 168 (04) :1759-1769